We found that HABP2 was not expressed in >300 of the 505 thyroid tumors included in the TCGA data set and was expressed at only low to moderate levels in the remaining tumors (Supplementary Fig. 2), indicating that HABP2 overexpression is not a common feature of papillary thyroid cancer. This evidence concerns the gene HABP2 and thyroid gland papillary carcinoma.